AbCellera Biologics Inc. (ABCL) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$3.35
Day's range
$3.56

AbCellera Biologics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BAKER BROS. ADVISORS LP 08/14/2026 33.01 M $259.15 M   9.04% 10.80%
CAPITAL WORLD INVESTORS 08/12/2026 13.59 M $106.67 M   1.70% 4.45%
TWO SIGMA INVESTMENTS, LP 08/14/2026 10.44 M $81.93 M   -1.18% 3.42%
TD WATERHOUSE CANADA INC. 07/27/2026 9.57 M $72.62 M   0.04% 3.13%
BANK OF AMERICA CORP /DE/ 08/14/2026 6.14 M $48.21 M   104.72% 2.01%
UBS ASSET MANAGEMENT AMERICAS INC 08/13/2026 4.32 M $33.89 M   -43.01% 1.41%
ARROWMARK COLORADO HOLDINGS LLC 08/13/2026 4.11 M $32.22 M   0.00% 1.34%
BLACKROCK, INC. 08/07/2026 3.81 M $29.87 M   -5.81% 1.25%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 2.89 M $22.66 M   216.76% 0.94%
DRIEHAUS CAPITAL MANAGEMENT LLC 08/14/2026 2.86 M $22.49 M   -28.82% 0.94%
TUDOR INVESTMENT CORP ET AL 08/14/2026 2.06 M $16.20 M   -9.25% 0.68%
MARSHALL WACE, LLP 08/13/2026 1.90 M $14.93 M   428.85% 0.62%
UBS GROUP AG 08/13/2026 1.87 M $14.68 M   -55.56% 0.61%
MORGAN STANLEY 08/13/2026 1.67 M $13.10 M   -24.98% 0.55%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 1.59 M $12.47 M   100.00% 0.52%
CITADEL ADVISORS LLC 09/02/2026 1.59 M $12.45 M   16.56% 0.52%
NATIONAL BANK OF CANADA /FI/ 08/10/2026 1.23 M $9.68 M   88,415.00% 0.40%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 08/13/2026 1.04 M $8.16 M   100.00% 0.34%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 990.93 K $7.78 M   -34.40% 0.32%
COUNTERPOINT MUTUAL FUNDS LLC 07/20/2026 971.64 K $7.63 M   100.00% 0.32%
CITADEL ADVISORS LLC 09/02/2026 790.30 K $6.20 M   84.00% 0.26%
STATE STREET CORP 09/22/2026 731.36 K $5.74 M   0.16% 0.24%
HRT FINANCIAL LP 08/14/2026 705.51 K $5.54 M   -42.88% 0.23%
DNB ASSET MANAGEMENT AS 08/11/2026 677.48 K $5.32 M   100.00% 0.22%
GUARDIAN PARTNERS INC. 07/29/2026 596.00 K $4.68 M   -66.64% 0.20%
DAIWA SECURITIES GROUP INC. 07/31/2026 561.50 K $4.41 M   100.00% 0.18%
INTELLECTUS PARTNERS, LLC 08/12/2026 551.58 K $4.33 M   1.01% 0.18%
ALYESKA INVESTMENT GROUP, L.P. 08/14/2026 526.58 K $4.13 M   -79.69% 0.17%
MILLENNIUM MANAGEMENT LLC 08/14/2026 518.57 K $4.07 M   -59.94% 0.17%
BANK OF MONTREAL /CAN/ 08/12/2026 482.80 K $3.79 M   165.73% 0.16%
SCULPTOR CAPITAL LP 08/14/2026 454.00 K $3.56 M   100.00% 0.15%
ADVISOR GROUP HOLDINGS, INC. 08/14/2026 407.90 K $3.20 M   16.88% 0.13%
ROYAL BANK OF CANADA 08/14/2026 403.32 K $3.17 M   2.17% 0.13%
BANK OF MONTREAL /CAN/ 08/12/2026 403.10 K $3.16 M   100.00% 0.13%
STATE OF MICHIGAN RETIREMENT SYSTEM 07/30/2026 400.00 K $3.14 M   0.00% 0.13%
CITADEL ADVISORS LLC 09/02/2026 372.30 K $2.92 M   326.95% 0.12%
SOFTBANK GROUP CORP. 08/14/2026 345.16 K $2.71 M   0.00% 0.11%
DECKER RETIREMENT PLANNING INC. 07/16/2026 336.11 K $2.64 M   100.00% 0.11%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 315.72 K $2.48 M   2.05% 0.10%
DAIWA SECURITIES GROUP INC. 07/31/2026 311.50 K $2.45 M   100.00% 0.10%
NORTHERN TRUST CORP 08/13/2026 298.62 K $2.34 M   45.94% 0.10%
DAIWA SECURITIES GROUP INC. 07/31/2026 250.00 K $1.96 M   100.00% 0.08%
HEADLANDS TECHNOLOGIES LLC 08/13/2026 246.25 K $1.93 M   34.82% 0.08%
EXODUSPOINT CAPITAL MANAGEMENT, LP 08/14/2026 237.95 K $1.87 M   66.70% 0.08%
GOLDMAN SACHS GROUP INC 08/14/2026 235.13 K $1.85 M   -93.73% 0.08%
MAN GROUP PLC 08/14/2026 228.98 K $1.80 M   100.00% 0.07%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 215.80 K $1.69 M   -59.60% 0.07%
CITIZENS FINANCIAL GROUP INC/RI 08/07/2026 211.89 K $1.66 M   -19.09% 0.07%
GSA CAPITAL PARTNERS LLP 08/06/2026 211.37 K $1.66 M   100.00% 0.07%
UBS GROUP AG 08/13/2026 200.00 K $1.57 M   100.00% 0.07%

AbCellera Biologics Inc institutional Ownership - FAQ's

During the previous two years, 207 institutional investors and hedge funds held shares of AbCellera Biologics Inc. The most heavily invested institutionals were:

BAKER BROS. ADVISORS LP: 33.01 M

Capital World Investors: 13.59 M

TWO SIGMA INVESTMENTS, LP: 10.44 M

TD Waterhouse Canada Inc.: 9.57 M

BANK OF AMERICA CORP /DE/: 6.14 M

UBS ASSET MANAGEMENT AMERICAS INC: 4.32 M

38.00% of AbCellera Biologics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 140.42 M shares in the last 24 months. This purchase volume represents approximately $494.29 M in transactions.